The emerging roles and mechanisms of FAM83H‑AS1 in cancer: Pathophysiology and therapeutic implications (Review)
Jin-Long Shi1, Chen-Shi Lin2, Ming-Hui Gong3
1Department of Cardio-Thoracic Surgery, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei 434000, P.R. China.
Abstract:
Long non-coding RNAs (lncRNAs) are key regulators of gene expression at transcriptional and post-transcriptional levels and serve roles in tumour progression, cancer diagnosis and prognosis. Among these, family with sequence similarity 83 member H-antisense RNA 1 (FAM83H-AS1) is an oncogenic lncRNA with elevated expression in several malignancies. FAM83H-AS1 promotes cancer cell proliferation, inhibits apoptosis, enhances migration and contributes to chemoresistance through interactions with microRNA (miR)-136-5p, miR-545-3p, miR-15a miR-10a-5p and signalling pathways such as Wnt/β-catenin and Notch receptor. FAM83H-AS1 may be a promising biomarker for cancer diagnosis and prognosis. The present review summarises the expression, mechanism and potential clinical application of FAM83H-AS1 in cancer diagnosis and prognosis.
Insights
Family with sequence similarity 83 member H-antisense RNA 1 (FAM83H-AS1) is an oncogenic long non-coding RNA that promotes cancer progression and may serve as a diagnostic and prognostic biomarker.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (lncRNAs) regulate gene expression and are implicated in cancer progression, diagnosis, and prognosis.
- Family with sequence similarity 83 member H-antisense RNA 1 (FAM83H-AS1) is an oncogenic lncRNA overexpressed in various malignancies.
Purpose of the Study:
- To review the expression patterns of FAM83H-AS1 in cancer.
- To elucidate the underlying mechanisms of FAM83H-AS1's oncogenic functions.
- To explore the potential of FAM83H-AS1 as a clinical biomarker for cancer diagnosis and prognosis.
Main Methods:
- Literature review of studies on FAM83H-AS1 in cancer.
- Analysis of FAM83H-AS1 expression data in different cancer types.
- Investigation of FAM83H-AS1's molecular interactions with microRNAs and signaling pathways.
Main Results:
- FAM83H-AS1 expression is elevated in several types of cancer.
- FAM83H-AS1 promotes cancer cell proliferation, inhibits apoptosis, enhances migration, and confers chemoresistance.
- FAM83H-AS1 interacts with specific microRNAs (miR-136-5p, miR-545-3p, miR-15a, miR-10a-5p) and signaling pathways (Wnt/β-catenin, Notch receptor).
Conclusions:
- FAM83H-AS1 plays a significant role in oncogenesis through various molecular mechanisms.
- FAM83H-AS1 holds promise as a potential biomarker for cancer diagnosis and prognosis.
- Further clinical studies are warranted to validate FAM83H-AS1's utility in cancer management.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Mitogens and the Cell Cycle
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...


